BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 83018)

  • 1. The operation of immunological networks in Graves' disease.
    Farid NR; Newton RM; Noel EP; Barnard JM; Marshall WH
    Tissue Antigens; 1978 Sep; 12(3):205-11. PubMed ID: 83018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of IgG heavy-chain allotypes (Gm) with Graves' disease in Hungary.
    Kozma L; Stenszky V; Kraszits E; Balazs C; Farid NR
    Exp Clin Immunogenet; 1985; 2(3):154-7. PubMed ID: 3939975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics of Hashimoto's and Graves' diseases.
    Tamai H; Uno H; Hirota Y; Matsubayashi S; Kuma K; Matsumoto H; Kumagai LF; Sasazuki T; Nagataki S
    J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic factors in Graves' ophthalmopathy.
    Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HLA B w4/w6 diallelic system in Graves' disease.
    Farid NR; Barnard JM; Sampson L; Noel EP; Marshall WH
    Tissue Antigens; 1978 May; 11(5):394-8. PubMed ID: 581239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
    Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA B8 and Graves' disease (author's transl)].
    Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
    Ann Endocrinol (Paris); 1976; 37(4):219-26. PubMed ID: 1037358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of Graves' disease.
    Gossage AA; Munro DS
    Clin Endocrinol Metab; 1985 May; 14(2):299-330. PubMed ID: 2866051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease.
    Uno H; Sasazuki T; Tamai H; Matsumoto H
    Nature; 1981 Aug; 292(5825):768-70. PubMed ID: 6894965
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA antigens in a family with both parents and several siblings affected by Graves' disease.
    Fernández Castañer M; Potau MA; Reus JC; Ercilla MG
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):535-8. PubMed ID: 6405574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
    Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
    Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
    Farid NR; Barnard JM; Marshall WH
    Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
    Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.
    Farid NR; Barnard JM; Marshall WH; Woolfrey I; O'Driscoll RF
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens in Graves' disease.
    Bech K; Lumholtz B; Nerup J; Thomsen M; Platz P; Ryder LP; Svejgaard A; Siersbaek-Nielsen K; Hansen JM; Larsen JH
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):510-6. PubMed ID: 72471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of human leukocyte D locus related antigens in Graves' disease.
    Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
    J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
    Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8.
    Chopra IJ; Solomon DH; Chopra U; Yoshihara E; Terasaki PI; Smith F
    J Clin Endocrinol Metab; 1977 Jul; 45(1):45-54. PubMed ID: 406273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.